The Impact of Immunosuppression and Autoimmune Disease on Severe Outcomes in Patients Hospitalized with COVID-19

Immunosuppression (IS) and autoimmune disease (AD) are prevalent in patients with severe coronavirus disease 2019 (COVID-19), but their impact on its clinical course is unknown. We investigated relationships between IS, AD, and outcomes in patients hospitalized with COVID-19. Data on consecutive adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Monreal, Enric, Sainz de la Maza, Susana, Fernández-Velasco, Jose Ignacio, Natera-Villalba, Elena, Rita, Claudia Geraldine, Rodríguez-Jorge, Fernando, Beltrán-Corbellini, Álvaro, Iturrieta-Zuazo, Ignacio, Rodríguez de Santiago, Enrique, Espiño, Mercedes, de Andrés, Ana, Fortún, Jesús, Barbero, Esther, Vázquez, Mónica, Fernández Lucas, Milagros, Manzano, Luis, Montero-Errasquín, Beatriz, Costa-Frossard, Lucienne, Masjuan, Jaime, Villar, Luisa María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685686/
https://www.ncbi.nlm.nih.gov/pubmed/33236261
http://dx.doi.org/10.1007/s10875-020-00927-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685686/
https://www.ncbi.nlm.nih.gov/pubmed/33236261
http://dx.doi.org/10.1007/s10875-020-00927-y

Ejemplares similares